golden, Amarin has $593M net cash as of 6/30/2020. It raised $460M last July, without it, it would only have $133M on its balance sheet now. Let's just get the number right before further discussion.
Gold, you can't compare oranges to apples. OSTK was a different set of circumstances. AMRN's secondary was discounted due to risk. Goldman and the other underwriters screwed the existing shareholders. Why do you think that everytime the stock makes a move the shorts are all over it. There are too many shs out in the float. The only way to get rid of the shorts in AMRN is a BO.
gold, as of June 30, 2019 Amrn had cash of $221 mill before the secondary. On July 19, 2019 they filed the form 425 raised approx $420 mill after commissions. They needed the proceeds to build out vascepa. In hindsight it's a good thing they raised that money, fast forward if they didn't raise the $420 the shareholders would be SOL as of today!!!